By James Mickleboro
Publication Date: 2025-12-08 00:23:00
Image source: Getty Images
Artrya Ltd (ASX: AYA) shares are starting the week with a bang.
In morning trade, ASX AI shares are up over 11% to $3.85.
Why is this ASX AI share jumping?
Investors bid the company’s shares higher today after it secured its second customer in the United States.
According to the press release, Artrya, a medical technology company that markets its AI-powered cloud platform Salix, has signed a commercial agreement with Northeast Georgia Health System.
Management believes this represents another important milestone in the Company’s accelerated expansion strategy in the United States.
Salix’s AI-powered cloud platform is used for near real-time point-of-care assessment and management of coronary heart disease.
The press release states that the three-year commercial agreement has a minimum value of $0.3 million, with additional fees per scan revenue from the Salix Coronary Plaque Module and, upon FDA approval, the Salix Coronary Flow Module.
The…
